Know Cancer

or
forgot password

Early Response Evaluation in Malignant Pleural Mesothelioma By Total Glycolytic Volume (TGV) Analysis of Serial FDG-PET Scans (Positron Emission Tomography Scans)


N/A
18 Years
N/A
Open (Enrolling)
Both
Malignant Pleural Mesothelioma

Thank you

Trial Information

Early Response Evaluation in Malignant Pleural Mesothelioma By Total Glycolytic Volume (TGV) Analysis of Serial FDG-PET Scans (Positron Emission Tomography Scans)


This is a retrospective analysis of two consecutive and homogeneous series of Malignant
Pleural Mesothelioma patients treated with first-line pemetrexed-based chemotherapy and
evaluated by CT scan and FDG-PET.


Inclusion Criteria:



- Histologically proven MALIGNANT PLEURAL MESOTHELIOMA

- Patients not candidate to radical surgery

- Unidimensionally and/or bidimensionally CT-measurable disease and Candidate to
first-line pemetrexed-based chemotherapy

Exclusion Criteria:

- Histologically not proven MALIGNANT PLEURAL MESOTHELIOMA

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

To validate a semi-automated iterative threshold-based region growing algorithm in a previously published series of patients.

Outcome Time Frame:

4 months

Safety Issue:

No

Principal Investigator

Armando Santoro, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Istituto Clinico Humanitas

Authority:

Italy: Ministry of Health

Study ID:

ONC/OSS-02/2009

NCT ID:

NCT00969098

Start Date:

June 2009

Completion Date:

October 2009

Related Keywords:

  • Malignant Pleural Mesothelioma
  • Histologically proven of Malignant pleural mesothelioma;
  • Patients not candidate to radical surgery;
  • Candidate to first-line pemetrexed-based chemotherapy;
  • Mesothelioma

Name

Location